Literature DB >> 31391925

Female infertility: which role for obesity?

Alessandra Gambineri1, Daniela Laudisio2, Chiara Marocco3, Stefano Radellini4, Annamaria Colao2, Silvia Savastano2.   

Abstract

Obesity is associated with infertility in women through multiple and complex mechanisms. Briefly, the adipose tissue through the production of many factors, such as leptin, free fatty acids (FFA), and cytokines may affect both ovarian and endometrium functions, with a final alteration in oocyte maturation and endometrial epithelium receptivity. In addition, through the development of peripheral insulin resistance obesity produces a condition of functional hyperandrogenism and hyperestrogenism that contribute to produce anovulation and to reduce endometrial receptivity and, therefore participate to cause infertility. Weight loss is able to restore fertility in most cases, but there are no practical indications to guide the clinician to choice the best method among increased physical activity, diet, drugs, and bariatric surgery.

Entities:  

Year:  2019        PMID: 31391925      PMCID: PMC6683114          DOI: 10.1038/s41367-019-0009-1

Source DB:  PubMed          Journal:  Int J Obes Suppl        ISSN: 2046-2166


  92 in total

Review 1.  Growth hormone: roles in female reproduction.

Authors:  K L Hull; S Harvey
Journal:  J Endocrinol       Date:  2001-01       Impact factor: 4.286

Review 2.  The insulin-related ovarian regulatory system in health and disease.

Authors:  L Poretsky; N A Cataldo; Z Rosenwaks; L C Giudice
Journal:  Endocr Rev       Date:  1999-08       Impact factor: 19.871

3.  Role of brain insulin receptor in control of body weight and reproduction.

Authors:  J C Brüning; D Gautam; D J Burks; J Gillette; M Schubert; P C Orban; R Klein; W Krone; D Müller-Wieland; C R Kahn
Journal:  Science       Date:  2000-09-22       Impact factor: 47.728

4.  The in vivo and in vitro effects of exogenous leptin on ovulation in the rat.

Authors:  P S Duggal; K H Van Der Hoek; C R Milner; N K Ryan; D T Armstrong; D A Magoffin; R J Norman
Journal:  Endocrinology       Date:  2000-06       Impact factor: 4.736

Review 5.  Pathophysiology and pharmacological treatment of insulin resistance.

Authors:  S Matthaei; M Stumvoll; M Kellerer; H U Häring
Journal:  Endocr Rev       Date:  2000-12       Impact factor: 19.871

6.  Insulin resistance in nonobese patients with polycystic ovary syndrome.

Authors:  S Toprak; A Yönem; B Cakir; S Güler; O Azal ; M Ozata; A Corakçi
Journal:  Horm Res       Date:  2001

7.  The impact of obesity and insulin resistance on the outcome of IVF or ICSI in women with polycystic ovarian syndrome.

Authors:  P Fedorcsák; P O Dale; R Storeng; T Tanbo; T Abyholm
Journal:  Hum Reprod       Date:  2001-06       Impact factor: 6.918

Review 8.  Leptin and reproduction: a review.

Authors:  Stergios Moschos; Jean L Chan; Christos S Mantzoros
Journal:  Fertil Steril       Date:  2002-03       Impact factor: 7.329

Review 9.  Obesity and the polycystic ovary syndrome.

Authors:  A Gambineri; C Pelusi; V Vicennati; U Pagotto; R Pasquali
Journal:  Int J Obes Relat Metab Disord       Date:  2002-07

10.  Leptin antagonizes the insulin-like growth factor-I augmentation of steroidogenesis in granulosa and theca cells of the human ovary.

Authors:  S K Agarwal; K Vogel; S R Weitsman; D A Magoffin
Journal:  J Clin Endocrinol Metab       Date:  1999-03       Impact factor: 5.958

View more
  16 in total

1.  Insights into Modifiable Risk Factors of Infertility: A Mendelian Randomization Study.

Authors:  Wentao Xu; Yueyuan You; Tianqi Yu; Jing Li
Journal:  Nutrients       Date:  2022-09-28       Impact factor: 6.706

Review 2.  Cellular Stress Responses in Oocytes: Molecular Changes and Clinical Implications.

Authors:  Waleed F A Marei; Jo L M R Leroy
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

Review 3.  Oral drug dosing following bariatric surgery: General concepts and specific dosing advice.

Authors:  Jurjen S Kingma; Desirée M T Burgers; Valerie M Monpellier; Marinus J Wiezer; Heleen J Blussé van Oud-Alblas; Janelle D Vaughns; Catherine M T Sherwin; Catherijne A J Knibbe
Journal:  Br J Clin Pharmacol       Date:  2021-06-03       Impact factor: 3.716

4.  Obesity, Insulin Resistance, and Hyperandrogenism Mediate the Link between Poor Diet Quality and Ovarian Dysmorphology in Reproductive-Aged Women.

Authors:  Maryam Kazemi; Brittany Y Jarrett; Heidi Vanden Brink; Annie W Lin; Kathleen M Hoeger; Steven D Spandorfer; Marla E Lujan
Journal:  Nutrients       Date:  2020-06-30       Impact factor: 5.717

5.  Review: Sex-Specific Aspects in the Bariatric Treatment of Severely Obese Women.

Authors:  Pia Jäger; Annina Wolicki; Johannes Spohnholz; Metin Senkal
Journal:  Int J Environ Res Public Health       Date:  2020-04-15       Impact factor: 3.390

Review 6.  Inositols in PCOS.

Authors:  Zdravko Kamenov; Antoaneta Gateva
Journal:  Molecules       Date:  2020-11-27       Impact factor: 4.411

Review 7.  Revisiting the Impact of Local Leptin Signaling in Folliculogenesis and Oocyte Maturation in Obese Mothers.

Authors:  Karolina Wołodko; Juan Castillo-Fernandez; Gavin Kelsey; António Galvão
Journal:  Int J Mol Sci       Date:  2021-04-20       Impact factor: 5.923

8.  Obstetrician-Gynecologists' Strategies for Patient Initiation and Maintenance of Antiobesity Treatment with Glucagon-Like Peptide-1 Receptor Agonists.

Authors:  Lisa Gill; Suzanne Mackey
Journal:  J Womens Health (Larchmt)       Date:  2021-02-24       Impact factor: 2.681

Review 9.  An Update on the Progress of Endometrial Receptivity in Women with Polycystic Ovary Syndrome.

Authors:  Jinyan Zhao; Qing Chen; Xiang Xue
Journal:  Reprod Sci       Date:  2021-06-02       Impact factor: 2.924

Review 10.  Fundamental Concepts and Novel Aspects of Polycystic Ovarian Syndrome: Expert Consensus Resolutions.

Authors:  Antonio Aversa; Sandro La Vignera; Rocco Rago; Alessandra Gambineri; Rossella E Nappi; Aldo E Calogero; Alberto Ferlin
Journal:  Front Endocrinol (Lausanne)       Date:  2020-08-11       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.